英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

jinni    
n. [回教神话] 神灵;神仙

[回教神话] 神灵;神仙

jinni
n 1: (Islam) an invisible spirit mentioned in the Koran and
believed by Muslims to inhabit the earth and influence
mankind by appearing in the form of humans or animals [synonym:
{genie}, {jinni}, {jinnee}, {djinni}, {djinny}, {djinn}]

Jinnee \Jin"nee\, Jinni \Jin"ni\(j[i^]n"n[=e]), n.; pl. {Jinn}
(j[i^]n). [Ar.] (Arabian & Mohammedan Myth.)
A genius or demon; one of the fabled genii, good and evil
spirits, supposed to be the children of fire, and to have the
power of assuming various forms. [Written also {djinnee},
{genie}, etc.]

Syn: jinn; jin; djinn.
[1913 Webster]

Note: Jinn is also used as sing., with pl. jinns.
[1913 Webster]


请选择你想看的字典辞典：
单词字典翻译
Jinni查看　Jinni　在百度字典中的解释百度英翻中〔查看〕
Jinni查看　Jinni　在Google字典中的解释Google英翻中〔查看〕
Jinni查看　Jinni　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Pfizer: One of the worlds premier biopharmaceutical companies
    Pfizer RxPathways Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings
  • Careers | Pfizer
    These programs can include health and disability insurance, preventative health programs, medical screening, free or reduced-cost vaccinations, discounts on Pfizer products, and nutrition and fitness counseling
  • Our Products: Holding the Promise of a Breakthrough | Pfizer
    In this section find an overview of our Pfizer Products and search for information on our most popular Pfizer products Our products are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription
  • Newsroom - Pfizer
    Pfizer surveyed adults in 10 countries across the Global North and South to better understand the general population's trust in incorporating technology into the management of their healthcare The results showed that 6 in 10 trust technology in this setting but that means 4 in 10 are at risk of being left behind
  • Pfizer’s Core Values of Social Responsibility and Philanthropy
    The Best Get Better—Pfizer and Warner-Lambert merge to form the new Pfizer, creating the world's fastest-growing major pharmaceutical company Learn more about the Pfizer Warner-Lambert merger
  • Pfizer Company Fact Sheet | Key Pharma Consumer Health Products | Pfizer
    At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products
  • Our Science: Pharmaceutical Development - Pfizer
    Science Drives Everything Pfizer Research Development is a key contributor to scientific breakthroughs, with more than 414 million patients reached globally with our medicines and vaccines in 2024 1,2
  • Press Releases - Pfizer
    Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts Financial Finance 03 23 2026 Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial Research and Pipeline Research 03 20 2026 Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC
  • New Drug Development Pipeline: Pfizers Medicine, Vaccine Discovery . . .
    This section defines all the terms you’ll see throughout the Pfizer Product Pipeline You can tap the (i) wherever you see it in the experience to be brought to this glossary Clinical trials are divided into four sequential phases Phase 1 studies help scientists understand the safety and correct dosing of an investigational medicine or vaccine
  • Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to . . .
    This release contains forward-looking information abouttilrekimig (PF-07275315), an investigational trispecific antibody, including its potential benefits; results from the Phase 2 study of tilrekimig in participants with moderate to severe atopic dermatitis; Pfizer’s investigational inflammation and immunology portfolio, and anticipated





中文字典-英文字典  2005-2009